IVACAFTOR\LUMACAFTOR: 8,110 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
8,110
Total FAERS Reports
142 (1.8%)
Deaths Reported
4,157
Hospitalizations
8,110
As Primary/Secondary Suspect
26
Life-Threatening
8
Disabilities
First Report: 20121212 · Latest Report: 20250811
What Are the Most Common IVACAFTOR\LUMACAFTOR Side Effects?
#1 Most Reported
Infective pulmonary exacerbation of cystic fibrosis
1,417 reports (17.5%)
#2 Most Reported
Hospitalisation
859 reports (10.6%)
#3 Most Reported
Dyspnoea
528 reports (6.5%)
All IVACAFTOR\LUMACAFTOR Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Infective pulmonary exacerbation of cystic fibrosis | 1,417 | 17.5% | 26 | 1,212 |
| Hospitalisation | 859 | 10.6% | 6 | 845 |
| Dyspnoea | 528 | 6.5% | 1 | 211 |
| Pulmonary function test decreased | 378 | 4.7% | 2 | 263 |
| Cough | 363 | 4.5% | 1 | 127 |
| Infection | 343 | 4.2% | 2 | 190 |
| Chest discomfort | 335 | 4.1% | 1 | 84 |
| Cystic fibrosis | 254 | 3.1% | 10 | 221 |
| Pneumonia | 233 | 2.9% | 4 | 196 |
| Malaise | 219 | 2.7% | 3 | 106 |
| Nasopharyngitis | 199 | 2.5% | 1 | 63 |
| Respiration abnormal | 191 | 2.4% | 1 | 88 |
| Fatigue | 190 | 2.3% | 0 | 68 |
| Diarrhoea | 186 | 2.3% | 0 | 47 |
| Influenza | 178 | 2.2% | 2 | 88 |
| Nausea | 175 | 2.2% | 0 | 55 |
| Pyrexia | 159 | 2.0% | 2 | 88 |
| Cystic fibrosis respiratory infection suppression | 144 | 1.8% | 0 | 143 |
| Vomiting | 144 | 1.8% | 0 | 52 |
| Headache | 137 | 1.7% | 0 | 31 |
Who Reports IVACAFTOR\LUMACAFTOR Side Effects? Age & Gender Data
Gender: 52.4% female, 47.6% male. Average age: 19.8 years. Most reports from: US. View detailed demographics →
Is IVACAFTOR\LUMACAFTOR Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2012 | 1 | 0 | 0 |
| 2013 | 1 | 0 | 0 |
| 2014 | 6 | 0 | 3 |
| 2015 | 557 | 11 | 261 |
| 2016 | 1,025 | 34 | 643 |
| 2017 | 1,178 | 18 | 742 |
| 2018 | 1,192 | 23 | 740 |
| 2019 | 1,384 | 9 | 799 |
| 2020 | 300 | 0 | 149 |
| 2021 | 67 | 1 | 42 |
| 2022 | 70 | 2 | 45 |
| 2023 | 39 | 2 | 20 |
| 2024 | 27 | 0 | 9 |
| 2025 | 6 | 0 | 5 |
What Is IVACAFTOR\LUMACAFTOR Used For?
| Indication | Reports |
|---|---|
| Cystic fibrosis | 7,864 |
| Product used for unknown indication | 33 |
| Pseudomonas infection | 8 |
IVACAFTOR\LUMACAFTOR vs Alternatives: Which Is Safer?
IVACAFTOR\LUMACAFTOR vs IVACAFTOR\TEZACAFTOR
IVACAFTOR\LUMACAFTOR vs IVERMECTIN
IVACAFTOR\LUMACAFTOR vs IVOSIDENIB
IVACAFTOR\LUMACAFTOR vs IXABEPILONE
IVACAFTOR\LUMACAFTOR vs IXAZOMIB
IVACAFTOR\LUMACAFTOR vs IXEKIZUMAB
IVACAFTOR\LUMACAFTOR vs JAKAFI
IVACAFTOR\LUMACAFTOR vs JAKAVI
IVACAFTOR\LUMACAFTOR vs JANUMET
IVACAFTOR\LUMACAFTOR vs JANUVIA
Official FDA Label for IVACAFTOR\LUMACAFTOR
Official prescribing information from the FDA-approved drug label.